FDA Warns of Testosterone Heart Attack Risk, Mandates Label Changes
![](https://drugreporter.com/wp-content/uploads/2014/03/androgel1-low-140x120.jpg)
On March 3, the U.S. Food and Drug Administration issued a warning on the testosterone heart attack risk for males using supplements to combat low levels of testosterone caused by aging. The FDA has required a labeling change to inform patients and the medical community of the possible increased risk... Read more »